These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 28709622)
1. Genipin protects d-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the necroptosis-mediated inflammasome signaling. Seo MJ; Hong JM; Kim SJ; Lee SM Eur J Pharmacol; 2017 Oct; 812():128-137. PubMed ID: 28709622 [TBL] [Abstract][Full Text] [Related]
2. Genipin protects lipopolysaccharide-induced apoptotic liver damage in D-galactosamine-sensitized mice. Kim SJ; Kim JK; Lee DU; Kwak JH; Lee SM Eur J Pharmacol; 2010 Jun; 635(1-3):188-93. PubMed ID: 20303938 [TBL] [Abstract][Full Text] [Related]
3. NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1. Kim SJ; Lee SM Free Radic Biol Med; 2013 Dec; 65():997-1004. PubMed ID: 23994575 [TBL] [Abstract][Full Text] [Related]
4. Necrostatin-1 Protects Against D-Galactosamine and Lipopolysaccharide-Induced Hepatic Injury by Preventing TLR4 and RAGE Signaling. Kim SJ; Lee SM Inflammation; 2017 Dec; 40(6):1912-1923. PubMed ID: 28752362 [TBL] [Abstract][Full Text] [Related]
5. Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation. Liu X; Wang T; Liu X; Cai L; Qi J; Zhang P; Li Y Int Immunopharmacol; 2016 Sep; 38():324-31. PubMed ID: 27344638 [TBL] [Abstract][Full Text] [Related]
6. Propofol attenuates inflammatory response and apoptosis to protect d-galactosamine/lipopolysaccharide induced acute liver injury via regulating TLR4/NF-κB/NLRP3 pathway. Zhang Z; Tian L; Jiang K Int Immunopharmacol; 2019 Dec; 77():105974. PubMed ID: 31735662 [TBL] [Abstract][Full Text] [Related]
7. Mangiferin alleviates lipopolysaccharide and D-galactosamine-induced acute liver injury by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation. Pan CW; Pan ZZ; Hu JJ; Chen WL; Zhou GY; Lin W; Jin LX; Xu CL Eur J Pharmacol; 2016 Jan; 770():85-91. PubMed ID: 26668000 [TBL] [Abstract][Full Text] [Related]
8. NLRP3 is dispensable for d-galactosamine/lipopolysaccharide-induced acute liver failure. Zhang W; Tao SS; Wang T; Li YT; Chen H; Zhan YQ; Yu M; Ge CH; Li CY; Ren GM; Yin RH; Yang XM Biochem Biophys Res Commun; 2020 Dec; 533(4):1184-1190. PubMed ID: 33041005 [TBL] [Abstract][Full Text] [Related]
9. Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure. Kim SJ; Cho HI; Kim SJ; Park JH; Kim JS; Kim YH; Lee SK; Kwak JH; Lee SM Eur J Pharmacol; 2014 Sep; 738():66-73. PubMed ID: 24877692 [TBL] [Abstract][Full Text] [Related]
10. β-Caryophyllene alleviates D-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the TLR4 and RAGE signaling pathways. Cho HI; Hong JM; Choi JW; Choi HS; Hwan Kwak J; Lee DU; Kook Lee S; Lee SM Eur J Pharmacol; 2015 Oct; 764():613-621. PubMed ID: 26254779 [TBL] [Abstract][Full Text] [Related]
11. Withaferin A alleviates fulminant hepatitis by targeting macrophage and NLRP3. Xia Y; Wang P; Yan N; Gonzalez FJ; Yan T Cell Death Dis; 2021 Feb; 12(2):174. PubMed ID: 33574236 [TBL] [Abstract][Full Text] [Related]
12. Diallyl sulfide protects against lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting oxidative stress, inflammation and apoptosis in mice. Li M; Wang S; Li X; Jiang L; Wang X; Kou R; Wang Q; Xu L; Zhao N; Xie K Food Chem Toxicol; 2018 Oct; 120():500-509. PubMed ID: 30075314 [TBL] [Abstract][Full Text] [Related]
13. Isoliquiritigenin alleviates LPS/ D-GalN-induced acute liver failure by activating the PGC-1α/ Nrf2 pathway to reduce oxidative stress and inflammatory response. Wang L; Wang X; Kong L; Wang S; Huang K; Wu J; Wang C; Sun H; Liu K; Meng Q Int Immunopharmacol; 2021 Nov; 100():108159. PubMed ID: 34555641 [TBL] [Abstract][Full Text] [Related]
14. Anoectochilus roxburghii polysaccharide reduces D-GalN/LPS-induced acute liver injury by regulating the activation of multiple inflammasomes. Yan Y; Ye X; Huang C; Wu J; Liu Y; Zheng P; Shen C; Bai Z; Tingming S J Pharm Pharmacol; 2024 Sep; 76(9):1212-1224. PubMed ID: 38985664 [TBL] [Abstract][Full Text] [Related]
15. Echinacoside ameliorates D-galactosamine plus lipopolysaccharide-induced acute liver injury in mice via inhibition of apoptosis and inflammation. Li X; Gou C; Yang H; Qiu J; Gu T; Wen T Scand J Gastroenterol; 2014 Aug; 49(8):993-1000. PubMed ID: 24797709 [TBL] [Abstract][Full Text] [Related]
16. RIP3 dependent NLRP3 inflammasome activation is implicated in acute lung injury in mice. Chen J; Wang S; Fu R; Zhou M; Zhang T; Pan W; Yang N; Huang Y J Transl Med; 2018 Aug; 16(1):233. PubMed ID: 30126430 [TBL] [Abstract][Full Text] [Related]
17. Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice. Pourcet B; Zecchin M; Ferri L; Beauchamp J; Sitaula S; Billon C; Delhaye S; Vanhoutte J; Mayeuf-Louchart A; Thorel Q; Haas JT; Eeckhoute J; Dombrowicz D; Duhem C; Boulinguiez A; Lancel S; Sebti Y; Burris TP; Staels B; Duez HM Gastroenterology; 2018 Apr; 154(5):1449-1464.e20. PubMed ID: 29277561 [TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine attenuates lipopolysaccharide-induced apoptotic liver damage in D-galactosamine-sensitized mice. Wang H; Xu DX; Lu JW; Zhao L; Zhang C; Wei W Acta Pharmacol Sin; 2007 Nov; 28(11):1803-9. PubMed ID: 17959032 [TBL] [Abstract][Full Text] [Related]
19. Protective mechanisms of wogonoside against Lipopolysaccharide/D-galactosamine-induced acute liver injury in mice. Gao YZ; Zhao LF; Ma J; Xue WH; Zhao H Eur J Pharmacol; 2016 Jun; 780():8-15. PubMed ID: 26921756 [TBL] [Abstract][Full Text] [Related]
20. Protective mechanisms of acacetin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure in mice. Cho HI; Park JH; Choi HS; Kwak JH; Lee DU; Lee SK; Lee SM J Nat Prod; 2014 Nov; 77(11):2497-503. PubMed ID: 25382719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]